研究課題
We generated hypoimmunogenic cancer-antigen-specific T cells derived from induced pluripotent stem cells (iPSCs) lacking β2-microglobulin, the class-II major histocompatibility complex (MHC) transactivator and the natural killer (NK) cell-ligand poliovirus receptor CD155, and expressing single-chain MHC class-I antigen E. In mouse models of CD20-expressing B-Lymphoblastoid cells, differentiated T cells expressing a CD20 chimeric antigen receptor largely escaped recognition by NKG2A+ and DNAM-1+ NK cells and by CD8 and CD4 T cells in the allogeneic recipients while maintaining antitumour potency.
すべて 2021 2020 その他
すべて 雑誌論文 (1件) (うち国際共著 1件、 査読あり 1件、 オープンアクセス 1件) 学会発表 (1件) 備考 (2件)
Nature Biomedical Engineering
巻: in press ページ: in press
10.1038/s41551-021-00730-z
https://www.cira.kyoto-u.ac.jp/
http://www.cira.kyoto-u.ac.jp/kaneko/index.html